BioSpace News Archive

Business

BioSpace Movers & Shakers, Sept. 25

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers and Shakers.

September 24, 2020
·
6 min read
·
Alex Keown
Deals

Taysha Makes Rapid Ascent from Launch to IPO

Starting with $30 million in seed financing in April, Taysha sprinted through a $95 million Series B in August and rounded the corner this Thursday to bring in $157 million for its IPO.

September 24, 2020
·
2 min read
·
Kate Goodwin
Drug Development

What Next-Generation COVID-19 Antibody Therapeutics Need to Succeed

First-generation therapeutics have been largely ineffective against the SARS-CoV-2 virus, resulting in significant challenges and opportunities for the second-generation therapeutics that are being designed now.

September 24, 2020
·
4 min read
·
Gail Dutton
Job Trends

Sanofi’s Toujeo Improves Diabetes Control, Giving Patients More Time in Range

For diabetic patients, achieving a certain “time in range” is a more realistic glucose control strategy than striving for a particular daily target, according to researchers working with Sanofi who spoke during the 56th Annual Meeting of the European Association for the Study of Diabetes.

September 24, 2020
·
5 min read
·
Gail Dutton
Vifor Pharma announces outcome of AFFIRM-AHF topline data

Vifor Pharma announced topline data from its AFFIRM-AHF study evaluating the effect of Ferinject® on heart failure hospitalizations and cardiovascular mortality in iron-deficient patients hospitalized for acute heart failure, compared to placebo.

September 24, 2020
·
3 min read
Drug Development

Poxel Presents Imeglimin Phase 3 TIMES Results and PXL770 Preclinical Cardio-Renal Results at the 56th European Association for the Study of Diabetes Annual Meeting

POXEL SA announced that it presented Imeglimin Phase 3 results for TIMES 2 and TIMES 3 and new preclinical results for PXL770 in a cardio-renal disease model at the 56th European Association for the Study of Diabetes Annual Meeting, which is being held virtually.

September 24, 2020
·
10 min read
Biotech Bay

Indivior Takes Strategic Alignment Actions

Indivior PLC announced that it is taking organizational and cost actions to better align its capabilities and resources with the Group’s strategic priorities.

September 24, 2020
·
17 min read
Integumen PLC: Unveiling of new breath test/dig’l health platform

Heads of Agreement with Avacta and Aptamer Group for commercial scale supply of SARS-CoV-2 binding agents

September 24, 2020
·
2 min read
Allergy Immunotherapy Market: Increased Funding for R&D Activities to Fuel Market Growth

The global market for allergy immunotherapy was initially valued at US$1.37 bn back in the year 2016.

September 24, 2020
·
4 min read
Animal Pregnancy Test Kits Market: Ѕеgmеnt Оutlооk, Соmреtіtіоn Ѕсеnаrіо, Тrеndѕ аnd Fоrесаѕt

Animal Pregnancy Test Kits are rapid response kits used to determine the pregnancy status of an animal.

September 24, 2020
·
5 min read